跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection vial
Approved
STANDARD
PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection vial
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d40c018a63253394
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
d40c018a63253394
Product Name
PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection vial
Artg Id
10507
Artg Name
PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection vial
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
1991-07-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/565808fa596dafc60e542d4d27d09c7a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/753c8643ad7882b5172f3136ce9ff036.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d40c018a63253394
Type
Standard
Back to TGA Approvals